from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3454/-

LFCtreatmentdescriptionclass of inhibitor

0.566

Amikacinug/mL Amikacintranslation

1.406

Cap5-10ug/mL Capreomycintranslation

1.925

Rox10-50 ug/mL Roxithromycintranslation

0.439

SM2-5 ug/mL Streptomycintranslation

1.043

Tet5-10 ug/mL Tetracyclinetranslation

-0.774

Rif0.2-5ug/mL Rifampicintranscription

0.131

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.506

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.950

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.885

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.381

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.344

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.269

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.958

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.117

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.035

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.917

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.804

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.112

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.417

KCN5-20 ug/mL Potassium cyaniderespiration

-0.170

NaN30.2-2 mM Sodium aziderespiration

0.191

Nigericin50 uM Nigericinrespiration

-0.883

TRC10-150 ug/mL Triclosanrespiration

-0.002

TRZ10-25 ug/mL Thioridazinerespiration

2.047

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.716

menadione6-10 ug/mL Menadionerespiration

-0.711

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.504

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.554

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.140

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.356

NRP_1Non-replicating persistence stage 1dosRassociated

0.632

Amp0.2mg/mL AmpicillincellWall

0.179

Cephalexin20-100 ug/mL CephalexincellWall

0.258

Cerulenin0.32-5 ug/mL CerulenincellWall

0.179

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.297

EMB10-20 ug/mL EthambutolcellWall

1.390

Eta12-40 ug/mL EthionamidecellWall

0.200

INH0.2-0.4 ug/mL IsoniazidcellWall

0.097

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.456

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.382

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.139

BZA0.12 mg/mL BenzamidearomaticAmides

0.278

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.707

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.505

H2O24 mM hydrogen peroxideDNAdamaging

0.211

Levo10 ug/mL LevofloxacinDNAdamaging

0.516

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.016

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.551

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.002

UVUV-irradiationDNAdamaging

-1.852

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.299

Antimycin12.5-50 ug/mL Antimycin A?

0.121

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.591

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.738

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.494

PA8240.2-2 ug/mL PA-824?

0.263

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.185

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.470

Verapamil50 uM Verapamil?

-0.102

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.186

methoxatin10-20 ug/mL Methoxatin?